Omics-guided surgical paradigms may identify specific patients for selective retroperitoneal clearance in advanced ovarian cancer
New Surgical Approach May Reduce Risks for Ovarian Cancer Patients
This systematic review examines the role of omics-guided surgery versus routine lymphadenectomy in advanced epithelial ovarian cancer. The a…
A new surgical model aims to reduce complications and identify specific patients who may benefit from targeted treatments for advanced ovari…
Osimertinib treatment for EGFR-mutated NSCLC results in hypertension as the most common CVAE
Osimertinib treatment for lung cancer shows specific heart risks
This meta-analysis of 10,316 patients with EGFR-mutated non-small cell lung cancer evaluated cardiovascular adverse events (CVAEs) associate…
New data identifies hypertension as the most common heart-related side effect for patients taking osimertinib for certain types of lung canc…
Neoadjuvant ICI plus chemotherapy improves event-free survival in early-stage TNBC
Adding immune drugs to chemo helps early stage triple negative breast cancer patients stay disease free longer
A meta-analysis found neoadjuvant immune checkpoint inhibitors with chemotherapy significantly improved event-free survival but not overall …
A large review of trials found that adding immune checkpoint inhibitors to chemotherapy improves survival chances for early stage triple neg…
Meta-analysis shows platinum-etoposide plus PD-1/PD-L1 inhibitor improves survival in extensive-stage small-cell lung cancer
Adding PD-1 or PD-L1 inhibitors improves survival for extensive-stage small-cell lung cancer
This meta-analysis of phase III trials evaluated platinum-etoposide combined with a PD-1 or PD-L1 inhibitor versus platinum-etoposide alone …
Adding a PD-1 or PD-L1 inhibitor to standard chemotherapy improves survival for extensive-stage small-cell lung cancer without increasing se…
Same-day desensitization linked to lower breakthrough reaction rate than rapid protocol in chemotherapy hypersensitivity
Can a same-day approach reduce allergic reactions during cancer treatment?
A retrospective cohort study of 120 patients with hypersensitivity reactions to platinum- or taxane-based chemotherapy compared same-day des…
A same-day desensitization approach reduced breakthrough allergic reactions to 15% compared to 24% for patients receiving rapid protocols du…